Search for: "Allergan Holdings, Inc." Results 61 - 80 of 118
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Apr 2014, 7:17 pm
     Procedural HistoryPlaintiffs- Appellants Senju Pharmaceutical Co., Ltd., Kyorin Phar- maceutical Co., Ltd., and Allergan, Inc. [read post]
16 Sep 2021, 12:57 pm by Simmons Hanly Conroy
” The New York State trial is expected to continue into October with remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
30 Jul 2021, 7:01 am by Simmons Hanly Conroy
The New York State opioid trial continues against three major drugmakers, Endo International Plc., Teva Pharmaceutical Industries Ltd., and AbbVie Inc’s Allergan unit, which all stand accused of having deceptively marketed their opioid painkillers. [read post]
20 Jun 2012, 12:38 pm by Edward M. McNally
The complaints alleged that the board of directors of Allergan Inc. was liable for failing to prevent Allergan from improperly marketing its Botox drug and thereby incurring a massive fine for doing so. [read post]
18 Jun 2012, 2:00 am by Keith Paul Bishop
  After the federal court dismissed the plaintiffs’ complaint pursuant to FRCP Rule 23.1 with prejudice (In re Allergan, Inc. [read post]
27 Jul 2018, 6:00 am by Kyle Kroll
Mylan Pharmaceuticals, Inc., 18-1638 (Fed. [read post]
27 Jul 2018, 6:00 am by Kyle Kroll
Mylan Pharmaceuticals, Inc., 18-1638 (Fed. [read post]
25 Oct 2010, 10:22 am by Stefanie Levine
Patent No. 7,405,203 owned by Allergan, Inc. and entitled PHARMACEUTICAL COMPOSITIONS INCLUDING LOW DOSAGES OF DESMOPRESSIN. [read post]
7 Sep 2011, 4:22 am by Marie Louise
(Kluwer Patent Blog) Fortical (Calcitonin-salmon) – US: Obviousness in chemical formulations: (unclaimed) purpose of limitation leads to nonobviousness holding: Unigene Labs. and Upsher-Smith Labs v. [read post]
16 Mar 2011, 12:26 pm by Bexis
Allergan USA, Inc., 2009 WL 3294873, at *2-5 (D. [read post]
29 May 2014, 3:44 am by Broc Romanek
Now Francis Pileggi of Eckert Seamans blogs this news: A proposed new addition and amendments to the Delaware General Corporation Law would limit the impact of a recent Delaware Supreme Court decision in ATP Tours, Inc. v. [read post]